Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.00
-0.1620 (-0.25%)
Apr 13, 2026, 9:36 AM EDT - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $87.3 million as of April 13, 2026. Its market cap has increased by 562.61% in one year.
Market Cap
87.30M
Enterprise Value
39.13M
1-Year Change
562.61%
Ranking
Category
Stock Price
n/a
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $87.30M, a decrease of -76.93%. That is a compound annual growth rate of -23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 87.30M | -6.37% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seer, Inc. | 95.35M |
| LeonaBio | 91.02M |
| Anixa Biosciences | 90.19M |
| Vivani Medical | 88.03M |
| Verrica Pharmaceuticals | 87.78M |
| Inovio Pharmaceuticals | 86.85M |
| Aardvark Therapeutics | 85.96M |
| PolyPid | 82.25M |